登革热蚊媒控制、疫苗与诊治的研究进展

doi:10.12183/j.scjpm.2024.0686

摘要/Abstract

摘要： 登革热是世界范围内最重要和传播最快的蚊媒病毒疾病之一。近年来随着环境的变化以及全球化的发展,登革热疾病负担加剧,已成为亟需预防和控制的重要传染病。登革热主要通过伊蚊传播,轻症患者可能会出现发热、疼痛等多种症状,重症患者可能会出现血浆渗漏、休克。目前,尚未有获得全球广泛许可的疫苗和治疗方法,预防主要依赖蚊媒控制和监测,而治疗则以对症、支持治疗为主。本研究对全球登革热的流行状况、蚊媒控制、诊断、治疗以及疫苗4个方面进行论述,为后续登革热的控制与研究方向提供依据。

关键词: 登革热, 伊蚊, 诊断, 治疗, 疫苗

中图分类号:

R183.5

吴跃千, 田亚锋, 唐慧, 常义坤, 陈津伟, 李俊熹, 杜志成. 登革热蚊媒控制、疫苗与诊治的研究进展[J]. 华南预防医学, 2024, 50(8): 686-690.

参考文献

[1] Castro MC,Wilson ME,Bloom DE.Disease and economic burdens of dengue[J].Lancet Infect Dis,2017,17(3):e70-e78.
[2] Ganeshkumar P,Murhekar MV,Poornima V,et al.Dengue infection in India:A systematic review and meta-analysis[J].PLoS Negl Trop Dis,2018,12(7):e0006618.
[3] Bhowmik KK,Ferdous J,Baral PK,et al.Recent outbreak of dengue in Bangladesh:A threat to public health[J].Health Sci Rep,2023,6(4):e1210.
[4] WHO.Dengue and severe dengue[EB/OL].(2024-04-23)[2024-05-23].https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
[5] Xu Z,Bambrick H,Frentiu FD,et al.Projecting the future of dengue under climate change scenarios:Progress,uncertainties and research needs[J].PLoS Negl Trop Dis,2020,14(3):e0008118.
[6] Ahmed AM,Mohammed AT,Vu TT,et al.Prevalence and burden of dengue infection in Europe:A systematic review and meta-analysis[J].Rev Med Virol,2020,30(2):e2093.
[7] Wilder-Smith A,Ooi EE,Horstick O,et al.Dengue[J].Lancet,2019,393(10169):350-363.
[8] Zeng Z,Zhan J,Chen L,et al.Global,regional,and national dengue burden from 1990 to 2017:A systematic analysis based on the global burden of disease study 2017[J].EClinicalMedicine,2021,32:100712.
[9] Messina JP,Brady OJ,Golding N,et al.The current and future global distribution and population at risk of dengue[J].Nat Microbiol,2019,4(9):1508-1515.
[10] Rodriguez-Barraquer I,Salje H,Cummings DA.Opportunities for improved surveillance and control of dengue from age-specific case data[J].Elife,2019,8:e45474.
[11] Sangkaew S,Ming D,Boonyasiri A,et al.Risk predictors of progression to severe disease during the febrile phase of dengue:A systematic review and meta-analysis[J].Lancet Infect Dis,2021,21(7):1014-1026.
[12] WHO.WHO scales up response to worldwide surge in dengue[EB/OL].(2019-11-14)[2024-01-14].https://www.who.int/news-room/feature-stories/detail/who-scales-up-response-to-worldwide-surge-in-dengue.
[13] Shepard DS,Undurraga EA,Halasa YA,et al.The global economic burden of dengue:A systematic analysis[J].Lancet Infect Dis,2016,16(8):935-941.
[14] Guzman MG,Gubler DJ,Izquierdo A,et al.Dengue infection[J].Nat Rev Dis Primers,2016,2:16055.
[15] Yue Y,Liu Q,Liu X,et al.Dengue fever in mainland China,2005-2020:A descriptive analysis of dengue cases and Aedes data[J].Int J Environ Res Public Health,2022,19(7):3910.
[16] Kularatne SA.Dengue fever[J].BMJ,2015,15:351:h4661.
[17] Lin H,Wang X,Li Z,et al.Epidemiological characteristics of dengue in mainland China from 1990 to 2019:A descriptive analysis[J].Medicine,2020,99(36):e21982.
[18] Yue Y,Liu X,Xu M,et al.Epidemiological dynamics of dengue fever in mainland China,2014-2018[J].Int J Infect Dis,2019,86:82-93.
[19] Kularatne SA,Dalugama C.Dengue infection:Global importance,immunopathology and management[J].Clin Med,2022,22(1):9-13.
[20] Kraemer MUG,Reiner RC Jr,Brady OJ,et al.Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus[J].Nat Microbiol,2019,4(5):854-863.
[21] Chandrasegaran K,Lahondère C,Escobar LE,et al.Linking mosquito ecology,traits,behavior,and disease transmission[J].Trends Parasitol,2020,36(4):393-403.
[22] Prasad A,Sreedharan S,Bakthavachalu B,et al.Eggs of the mosquito Aedes aegypti survive desiccation by rewiring their polyamine and lipid metabolism[J].PLoS Biol,2023,21(10):e3002342.
[23] 李晓宁,刘远,何蔚云.广州市蚊媒监测研究[J].寄生虫与医学昆虫学报,2021,28(2):134-138,184.
[24] 王龙昌,郑桂来,夏珊珊,等.我国登革热蚊媒监测概况及建议[J].绿色科技,2020(10):188-90.
[25] 闫冬明,黄坤,赵春春,等.常用蚊虫监测方法和技术研究进展[J].中国媒介生物学及控制杂志,2020,31(1):108-112.
[26] González-Pérez MI,Faulhaber B,Williams M,et al.A novel optical sensor system for the automatic classification of mosquitoes by genus and sex with high levels of accuracy[J].Parasit Vectors,2022,15(1):190.
[27] Santos DA,Rodrigues JJ,Furtado V,et al.Automated electronic approaches for detecting disease vectors mosquitoes through the wing-beat frequency[J].J Clean Prod,2019,217:767-775.
[28] Andersson N,Nava-Aguilera E,Arosteguí J,et al.Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde,the Green Way):Cluster randomized controlled trial[J].BMJ,2015,351:h3267.
[29] Van Dam AR,Walton WE.The effect of predatory fish exudates on the ovipostional behaviour of three mosquito species:Culex quinquefasciatus,Aedes aegypti and Culex tarsalis[J].Med Vet Entomol,2008,22(4):399-404.
[30] Vu SN,Nguyen TY,Tran VP,et al.Elimination of dengue by community programs using Mesocyclops(Copepoda) against Aedes aegypti in central Vietnam[J].Am J Trop Med Hyg,2005,72(1):67-73.
[31] Kay BH,Lyons SA,Holt JS,et al.Point source inoculation of Mesocyclops (Copepoda:Cyclopidae) gives widespread control of Ochlerotatus and Aedes (Diptera:Culicidae) immatures in service manholes and pits in north Queensland,Australia[J].J Med Entomol,2002,39(3):469-474.
[32] Darbro JM,Johnson PH,Thomas MB,et al.Effects of Beauveria bassiana on survival,blood-feeding success,and fecundity of Aedes aegypti in laboratory and semi-field conditions[J].Am J Trop Med Hyg,2012,86(4):656-664.
[33] Frentiu FD,Zakir T,Walker T,et al.Limited dengue virus replication in field-collected Aedes aegypti mosquitoes infected with Wolbachia[J].PLoS Negl Trop Dis,2014,8(2):e2688.
[34] Huang YS,Higgs S,Vanlandingham DL.Biological control strategies for mosquito vectors of arboviruses[J].Insects,2017,8(1):21.
[35] Paz-Bailey G,Adams L,Wong JM,et al.Dengue vaccine:Recommendations of the advisory Committee on Immunization Practices,United States,2021[J].MMWR Recomm Rep,2021,70(6):1-16.
[36] Heilman JM,De Wolff J,Beards GM,et al.Dengue fever:A Wikipedia clinical review[J].Open Med,2014,8(4):e105-115.
[37] Simmons CP,Farrar JJ,Nguyen vV,et al.Dengue[J].N Engl J Med,2012,366(15):1423-1432.
[38] Bos S,Gadea G,Despres P.Dengue:A growing threat requiring vaccine development for disease prevention[J].Pathog Glob Health,2018,112(6):294-305.
[39] 孙宁泽,郑晓燕.登革热诊治研究进展[J].中国医刊,2024,59(1):22-25.
[40] Kallás EG,Cintra MAT,Moreira JA,et al.Live,attenuated,tetravalent butantan-dengue vaccine in children and adults[J].N Engl J Med,2024,390(5):397-408.
[41] Hernandez-Morales I,Geluykens P,Clynhens M,et al.Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library[J].Antiviral Res,2017,147:149-158.
[42] Starvaggi J,Previti S,Zappalà M,et al.The inhibition of NS2B/NS3 protease:A new therapeutic opportunity to treat dengue and zika virus infection[J].Int J Mol Sci,2024,25(8):4376.
[43] Sun H,Chen Q,Lai H.Development of antibody therapeutics against flaviviruses[J].Int J Mol Sci,2017,19(1):54.
[44] Sootichote R,Puangmanee W,Benjathummarak S,et al.Potential protective effect of dengue NS1 human monoclonal antibodies against dengue and zika virus infections[J].Biomedicines,2023,11(1):227.
[45] WHO. Dengue vaccine:WHO position paper,September 2018 - Recommendations[J].Vaccine,2019,37(35):4848-4849.
[46] Sridhar S,Luedtke A,Langevin E,et al.Effect of dengue serostatus on dengue vaccine safety and efficacy[J].N Engl J Med,2018,379(4):327-340.
[47] Torres-Flores JM,Reyes-Sandoval A,Salazar MI.Dengue vaccines:An update[J].BioDrugs,2022,36(3):325-336.
[48] Okoye EC,Mitra AK,Lomax T,et al.Dengue fever epidemics and the prospect of vaccines:A systematic review and meta-Analysis using clinical trials in children[J].Diseases,2024,12(2):32.
[49] Paz-Bailey G,Adams LE,Deen J,et al.Dengue[J].Lancet,2024,403(10427):667-682.
[50] Rivera L,Biswal S,Sáez-Llorens X,et al.Three-year efficacy and safety of takeda's dengue vaccine candidate (TAK-003)[J].Clin Infect Dis,2022,75(1):107-117.
[51] Kallas EG,Precioso AR,Palacios R,et al.Safety and immunogenicity of the tetravalent,live-attenuated dengue vaccine butantan-DV in adults in Brazil:A two-step,double-blind,randomised placebo-controlled phase 2 trial[J].Lancet Infect Dis,2020,20(7):839-850.
[52] Wang L,Huang AT,Katzelnick LC,et al.Antigenic distance between primary and secondary dengue infections correlates with disease risk[J].Sci Transl Med,2024,16(744):eadk3259.